Patents by Inventor Herbert C. Mansmann, Jr.

Herbert C. Mansmann, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
    Patent number: 5939394
    Abstract: The present invention relates to compositions and methods for the prevention and/or treatment of allergic, autoimmune, septic shock or infectious diseases using magnesium gluconate alone or in combination with one or more antioxidants or an antiinflammatory agent. The invention also relates to the inhibition of production of inappropriate levels of lipid mediators and cytokines.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: August 17, 1999
    Assignee: Fleming & Company
    Inventors: Thomas E. Fleming, Herbert C. Mansmann, Jr.
  • Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength
    Patent number: 5922765
    Abstract: The present invention relates to methods and compositions for the prevention and/or treatment of exercise-induced muscle cramps, stiffness, pain or spasms, using magnesium gluconate alone or in combination with one or more antioxidants or conventional pharmacologic therapy. The invention also relates to inhibition of production of oxygenated molecules, oxygen free radicals and lipid peroxidation.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: July 13, 1999
    Assignee: Fleming & Company, Pharmaceuticals
    Inventors: Thomas E. Fleming, Herbert C. Mansmann, Jr.
  • Methods and compositions for the prevention and treatment of diabetes mellitus
    Patent number: 5871769
    Abstract: The present invention relates to methods and compositions for the prevention and/or treatment of diabetes mellitus, using magnesium gluconate alone or in combination with one or more antioxidants or conventional diet and/or insulin therapy. The invention also relates to inhibition of production of oxygen free radicals and lipid peroxidation.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: February 16, 1999
    Assignee: Fleming & Company, Pharmaceuticals
    Inventors: Thomas E. Fleming, Herbert C. Mansmann, Jr.